Joel M Gelfand

InstitutionUniversity of Pennsylvania Perelman School of Medicine
AddressPhiladelphia
Pennsylvania
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 2 publications in April 2020 and July 2020 and Spetember 2020
    All Publications
    Bar chart showing 187 publications over 20 distinct years, with a maximum of 20 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Gelfand JM, Armstrong AW, Bell S, Anesi GL, Blauvelt A, Calabrese C, Dommasch ED, Feldman SR, Gladman D, Kircik L, Lebwohl M, Lo Re V, Martin G, Merola JF, Scher JU, Schwartzman S, Treat JR, Van Voorhees AS, Ellebrecht CT, Fenner J, Ocon A, Syed MN, Weinstein EJ, Gondo G, Heydon S, Koons S, Ritchlin CT. National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments. J Am Acad Dermatol. 2021 05; 84(5):1254-1268. PMID: 33422626.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    2. Horton L, Torres AE, Narla S, Lyons AB, Kohli I, Gelfand JM, Ozog DM, Hamzavi IH, Lim HW. Spectrum of virucidal activity from ultraviolet to infrared radiation. Photochem Photobiol Sci. 2020 Oct 14; 19(10):1262-1270. PMID: 32812619.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    3. Gelfand JM, Armstrong AW, Bell S, Anesi GL, Blauvelt A, Calabrese C, Dommasch ED, Feldman SR, Feldman SR, Gladman D, Kircik L, Lebwohl M, Lo Re V, Martin G, Merola JF, Scher JU, Schwartzman S, Treat JR, Van Voorhees AS, Ellebrecht CT, Fenner J, Ocon A, Syed MN, Weinstein EJ, Smith J, Gondo G, Heydon S, Koons S, Ritchlin CT. National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1. J Am Acad Dermatol. 2020 Dec; 83(6):1704-1716. PMID: 32891785.
      Citations: 15     Fields:    Translation:HumansCellsPHPublic Health
    4. Gelfand JM, Hefele BE. Clinical Research after COVID-19: Embracing a New Normal. J Invest Dermatol. 2021 03; 141(3):481-483. PMID: 32890628.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    5. Syed MN, Shah M, Shin DB, Wan MT, Winthrop KL, Gelfand JM. Effect of anti-tumor necrosis factor therapy on the risk of respiratory tract infections and related symptoms in patients with psoriasis-A meta-estimate of pivotal phase 3 trials relevant to decision making during the COVID-19 pandemic. J Am Acad Dermatol. 2021 01; 84(1):161-163. PMID: 32860913.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    6. Wan MT, Shin DB, Winthrop KL, Gelfand JM. Reply to: "Do IL-17 inhibitors increase risk of respiratory tract infections?" J Am Acad Dermatol. 2020 10; 83(4):e305-e306. PMID: 32622146.
      Citations:    Fields:    Translation:HumansPHPublic Health
    7. Syed MN, Shin DB, Wan MT, Winthrop KL, Gelfand JM. The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic. J Am Acad Dermatol. 2020 11; 83(5):1523-1526. PMID: 32622891.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    8. Wan MT, Shin DB, Winthrop KL, Gelfand JM. The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic. J Am Acad Dermatol. 2020 08; 83(2):677-679. PMID: 32416207.
      Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
    9. Lim HW, Feldman SR, Van Voorhees AS, Gelfand JM. Recommendations for phototherapy during the COVID-19 pandemic. J Am Acad Dermatol. 2020 Jul; 83(1):287-288. PMID: 32339700.
      Citations: 10     Fields:    Translation:HumansCellsPHPublic Health
    10. Hamzavi IH, Lyons AB, Kohli I, Narla S, Parks-Miller A, Gelfand JM, Lim HW, Ozog DM. Ultraviolet germicidal irradiation: Possible method for respirator disinfection to facilitate reuse during the COVID-19 pandemic. J Am Acad Dermatol. 2020 06; 82(6):1511-1512. PMID: 32246972.
      Citations: 39     Fields:    Translation:HumansCellsPHPublic Health